Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease
Authors
Keywords
-
Journal
GUT
Volume 70, Issue 9, Pages 1782-1794
Publisher
BMJ
Online
2021-06-09
DOI
10.1136/gutjnl-2020-323888
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The changing scenario of hepatitis D
- (2021) Mario Rizzetto et al. JOURNAL OF HEPATOLOGY
- Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection
- (2021) Nina Hensel et al. NATURE IMMUNOLOGY
- Assembly and infection efficacy of hepatitis B virus surface protein exchanges in eight hepatitis D virus genotype isolates
- (2021) Wenshi Wang et al. JOURNAL OF HEPATOLOGY
- MAIT Cells in Health and Disease
- (2020) Nicholas M. Provine et al. Annual Review of Immunology
- Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies
- (2020) Dulce Alfaiate et al. JOURNAL OF HEPATOLOGY
- Hepatitis Delta Virus histone mimicry drives the recruitment of chromatin remodelers for viral RNA replication
- (2020) Natali Abeywickrama-Samarakoon et al. Nature Communications
- The global prevalence of hepatitis D virus infection: systematic review and meta-analysis
- (2020) Alexander J. Stockdale et al. JOURNAL OF HEPATOLOGY
- Innate Immunity in Hepatitis C Virus Infection
- (2020) Johannes Schwerk et al. Cold Spring Harbor Perspectives in Medicine
- Current knowledge on Hepatitis Delta Virus replication
- (2020) Julie Lucifora et al. ANTIVIRAL RESEARCH
- Animal models for the study of human hepatitis B and D virus infection: new insights and progress
- (2020) Benjamin J. Burwitz et al. ANTIVIRAL RESEARCH
- Preliminary evidence for hdv exposure in apparently non‐HBV‐infected patients
- (2020) Isabelle Chemin et al. HEPATOLOGY
- A Phase 2 Study of Peginterferon Lambda, Lonafarnib and Ritonavir for 24 Weeks: End-of-Treatment Results from the LIFT HDV Study
- (2020) Christopher Koh et al. JOURNAL OF HEPATOLOGY
- 48 weeks of high dose (10 mg) bulevirtide as monotherapy or with peginterferon alfa-2a in patients with chronic HBV/HDV co-infection
- (2020) Heiner Wedemeyer et al. JOURNAL OF HEPATOLOGY
- No Evidence of Hepatitis C Virus (HCV)–Assisted Hepatitis D Virus Propagation in a Large Cohort of HCV-Positive Blood Donors
- (2020) Pierre Cappy et al. JOURNAL OF INFECTIOUS DISEASES
- Hepatitis delta virus propagation enabled by hepatitis C virus—Scientifically intriguing, but is it relevant to clinical practice?
- (2020) Lisa Sophie Pflüger et al. JOURNAL OF VIRAL HEPATITIS
- New insights into HDV persistence: The role of interferon response and implications for upcoming novel therapies
- (2020) Zhenfeng Zhang et al. JOURNAL OF HEPATOLOGY
- Hepatitis D Virus-specific CD8+ T Cells Have a Memory-like Phenotype Associated With Viral Immune Escape in Patients With Chronic Hepatitis D Virus Infection
- (2019) Helenie Kefalakes et al. GASTROENTEROLOGY
- Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial
- (2019) Heiner Wedemeyer et al. LANCET INFECTIOUS DISEASES
- Combined small molecule and loss-of-function screen uncovers estrogen receptor alpha and CAD as host factors for HDV infection and antiviral targets
- (2019) Eloi R Verrier et al. GUT
- Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level
- (2019) Hadi Karimzadeh et al. GASTROENTEROLOGY
- Inhibition of HBsAg secretion by nucleic acid polymers in HepG2.2.15 cells
- (2019) Matthieu Blanchet et al. ANTIVIRAL RESEARCH
- SAT-202-Endogenous and exogenous IFN responses suppress HDV persistence during proliferation of hepatocytes in vitro
- (2019) Zhenfeng Zhang et al. JOURNAL OF HEPATOLOGY
- Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells
- (2019) Joana Dias et al. JOURNAL OF HEPATOLOGY
- Analysis of host responses to hepatitis B and delta viral infections in a micro-scalable hepatic co-culture system
- (2019) Benjamin Y. Winer et al. HEPATOLOGY
- Excellent safety and effectiveness of high dose myrcludex-b monotherapy administered for 48 weeks in hdv related compensated cirrhosis: a case report of three patients
- (2019) Alessandro Loglio et al. JOURNAL OF HEPATOLOGY
- Recapitulation of HDV infection in a fully permissive hepatoma cell line allows efficient drug evaluation
- (2019) Florian A. Lempp et al. Nature Communications
- Generation and characterization of a stable cell line persistently replicating and secreting the human hepatitis delta virus
- (2019) Yi Ni et al. Scientific Reports
- Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference
- (2019) Markus Cornberg et al. JOURNAL OF HEPATOLOGY
- Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection
- (2019) Zhijiang Miao et al. JOURNAL OF INFECTIOUS DISEASES
- Structural Pattern Differences in Unbranched Rod-like RNA of Hepatitis Delta Virus affect RNA Editing
- (2019) Hsu et al. Viruses-Basel
- Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver
- (2018) Aleksei Suslov et al. GASTROENTEROLOGY
- HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon
- (2018) Pascal Mutz et al. GASTROENTEROLOGY
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
- (2018) Norah A. Terrault et al. HEPATOLOGY
- Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection
- (2018) H. Wedemeyer et al. JOURNAL OF HEPATOLOGY
- Hepatitis D virus replication is sensed by MDA5 and induces IFN-β/λ responses in hepatocytes
- (2018) Zhenfeng Zhang et al. JOURNAL OF HEPATOLOGY
- Hepatitis B Virus DNA Integration Occurs Early in the Viral Life Cycle in an In Vitro Infection Model via Sodium Taurocholate Cotransporting Polypeptide-Dependent Uptake of Enveloped Virus Particles
- (2018) Thomas Tu et al. JOURNAL OF VIROLOGY
- Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8+ T Cells
- (2018) Hadi Karimzadeh et al. JOURNAL OF VIROLOGY
- Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections
- (2018) Thomas Tu et al. Current Opinion in Virology
- Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis
- (2018) Hai-Yan Chen et al. GUT
- Detection of a broad range of low level MHC class II-restricted Hepatitis Delta Virus (HDV)-specific T cell responses regardless of the clinical status
- (2018) Johanna Landahl et al. JOURNAL OF INFECTIOUS DISEASES
- REP 2139: antiviral mechanisms and applications in achieving functional control of HBV and HDV infection
- (2018) Andrew Vaillant ACS Infectious Diseases
- Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection
- (2018) Barbara Rehermann et al. GASTROENTEROLOGY
- Treating Chronic Hepatitis Delta: The Need for Surrogate Markers of Treatment Efficacy
- (2018) Cihan Yurdaydin et al. JOURNAL OF HEPATOLOGY
- Capturing variation impact on molecular interactions in the IMEx Consortium mutations data set
- (2018) N. del-Toro et al. Nature Communications
- Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivo
- (2017) Katja Giersch et al. GUT
- Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo
- (2017) Lena Allweiss et al. GUT
- Genetic diversity and worldwide distribution of the deltavirus genus: A study of 2,152 clinical strains
- (2017) Frédéric Le Gal et al. HEPATOLOGY
- A phase 2 study exploring once daily dosing of ritonavir boosted lonafarnib for the treatment of chronic delta hepatitis – end of study results from the LOWR HDV-3 study
- (2017) C. Koh et al. JOURNAL OF HEPATOLOGY
- A phase 2 dose-escalation study of lonafarnib plus ritonavir in patients with chronic hepatitis D: final results from the Lonafarnib with ritonavir in HDV-4 (LOWR HDV-4) study
- (2017) H. Wedemeyer et al. JOURNAL OF HEPATOLOGY
- A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis—end of treatment results from the LOWR HDV-2 study
- (2017) C. Yurdaydin et al. JOURNAL OF HEPATOLOGY
- EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
- (2017) Pietro Lampertico et al. JOURNAL OF HEPATOLOGY
- Nucleic acid polymers are active against Hepatitis Delta Virus infection in vitro.
- (2017) Frauke Beilstein et al. JOURNAL OF VIROLOGY
- RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg
- (2017) Christine I. Wooddell et al. Science Translational Medicine
- HBV DNA Integration: Molecular Mechanisms and Clinical Implications
- (2017) Thomas Tu et al. Viruses-Basel
- TCF1+ hepatitis C virus-specific CD8+ T cells are maintained after cessation of chronic antigen stimulation
- (2017) Dominik Wieland et al. Nature Communications
- Cytomegalovirus-Driven Adaptive-Like Natural Killer Cell Expansions Are Unaffected by Concurrent Chronic Hepatitis Virus Infections
- (2017) David F. G. Malone et al. Frontiers in Immunology
- HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes
- (2016) Dulce Alfaiate et al. ANTIVIRAL RESEARCH
- Adaptive immunity in HBV infection
- (2016) Antonio Bertoletti et al. JOURNAL OF HEPATOLOGY
- The Third Signal Cytokine Interleukin 12 Rather Than Immune Checkpoint Inhibitors Contributes to the Functional Restoration of Hepatitis D Virus–Specific T Cells
- (2016) Thomas Schirdewahn et al. JOURNAL OF INFECTIOUS DISEASES
- Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options
- (2016) Florian A. Lempp et al. Nature Reviews Gastroenterology & Hepatology
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
- (2015) S. K. Sarin et al. Hepatology International
- Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection
- (2015) Katja Giersch et al. JOURNAL OF HEPATOLOGY
- Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial
- (2015) Christopher Koh et al. LANCET INFECTIOUS DISEASES
- Long-term therapy of chronic delta hepatitis with peginterferon alfa
- (2014) T. Heller et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effects of HDV infection and pegylated interferon α treatment on the natural killer cell compartment in chronically infected individuals
- (2014) Sebastian Lunemann et al. GUT
- Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta
- (2014) Benjamin Heidrich et al. HEPATOLOGY
- Envelope Proteins Derived from Naturally Integrated Hepatitis B Virus DNA Support Assembly and Release of Infectious Hepatitis Delta Virus Particles
- (2014) N. Freitas et al. JOURNAL OF VIROLOGY
- Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes
- (2013) Yi Ni et al. GASTROENTEROLOGY
- Compromised Function of Natural Killer Cells in Acute and Chronic Viral Hepatitis
- (2013) Sebastian Lunemann et al. JOURNAL OF INFECTIOUS DISEASES
- Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
- (2012) Huan Yan et al. eLife
- Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation
- (2011) Ingmar Mederacke et al. JOURNAL OF HEPATOLOGY
- Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
- (2011) Heiner Wedemeyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Comprehensive Hepatitis C Viral Kinetic Model Explaining Cure
- (2010) E Snoeck et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Pre-S2 Domain of the Hepatitis B Virus Is Dispensable for Infectivity but Serves a Spacer Function for L-Protein-Connected Virus Assembly
- (2010) Y. Ni et al. JOURNAL OF VIROLOGY
- Hepatitis delta virus inhibits alpha interferon signaling
- (2008) Paolo Pugnale et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now